Published in Biokhimiia on February 01, 1981
Functional components of basic fibroblast growth factor signaling that inhibit lung elastin gene expression. Am J Physiol Lung Cell Mol Physiol (2001) 1.58
Folding of proteins with WD-repeats: comparison of six members of the WD-repeat superfamily to the G protein beta subunit. Biochemistry (1996) 1.48
Structure and functions of classical cadherins. Biochemistry (Mosc) (2001) 1.40
Arachidonic acid activates release of calcium ions from reticulum via ryanodine receptor channels in C2C12 skeletal myotubes. Biochemistry (Mosc) (2014) 1.39
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
Guanine nucleotide-dependent, pertussis toxin-insensitive regulation of phosphoinositide turnover by bradykinin in bovine pulmonary artery endothelial cells. FASEB J (1989) 1.04
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc) (2008) 1.04
T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett (1998) 1.03
Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry (Mosc) (2002) 1.01
Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. J Appl Physiol (1985) (1988) 0.97
Plasminogen activators in vascular remodeling and angiogenesis. Biochemistry (Mosc) (2002) 0.93
Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I. J Biol Chem (1982) 0.92
Density- and proliferation status-dependent expression of T-cadherin, a novel lipoprotein-binding glycoprotein: a function in negative regulation of smooth muscle cell growth? FEBS Lett (1998) 0.89
Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension. Hypertension (1986) 0.87
Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens (2000) 0.86
LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions. FEBS Lett (1999) 0.86
Endothelin-1 and endothelin-3 stimulate calcium mobilization by different mechanisms in vascular smooth muscle. Biochem Biophys Res Commun (1992) 0.86
Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains. J Recept Signal Transduct Res (1999) 0.86
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol Cell Biochem (1999) 0.86
Mesenchymal stem cells in tissue growth and repair. Acta Naturae (2011) 0.85
Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique. Biochem J (1996) 0.84
Involvement of Ni protein in the functional coupling of the atrial natriuretic factor (ANF) receptor to adenylate cyclase in rat lung plasma membranes. Eur J Biochem (1988) 0.84
Different electrical responses to vasoactive agonists in morphologically distinct smooth muscle cell types. Circ Res (1994) 0.84
[Mechanisms of Vascular Remodeling Following Arterial Injury]. Kardiologiia (2015) 0.83
Interaction of stable prostaglandin endoperoxide analogs U46619 and U44069 with human platelet membranes: coupling of receptors with high-affinity GTPase and adenylate cyclase. Thromb Res (1985) 0.83
Concerted effects of lipoproteins and angiotensin II on signal transduction processes in vascular smooth muscle cells. Arterioscler Thromb (1993) 0.83
Calmodulin activates adenylate cyclase from rabbit heart plasma membranes. FEBS Lett (1984) 0.83
Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells. J Cardiovasc Pharmacol (1988) 0.83
Mechanisms of mastoparan-stimulated surfactant secretion from isolated pulmonary alveolar type 2 cells. J Biol Chem (1991) 0.82
Activators of Epac proteins induce relaxation of isolated rat aorta. Dokl Biol Sci (2007) 0.82
[Adipose stromal cells--plastic type of cells with high therapeutic potential]. Tsitologiia (2006) 0.81
Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells. Mol Pharmacol (1994) 0.81
Heterotrimeric Gi protein is associated with the inositol 1,4,5-trisphosphate receptor complex and modulates calcium flux. Cell Calcium (1998) 0.80
Insulin resistance and adipogenesis: role of transcription and secreted factors. Biochemistry (Mosc) (2013) 0.80
Cellular signalling by lipoproteins in cultured smooth muscle cells from spontaneously hypertensive rats. J Vasc Res (1993) 0.80
Increased pressure induces sustained protein kinase C-independent herbimycin A-sensitive activation of extracellular signal-related kinase 1/2 in the rabbit aorta in organ culture. Circ Res (1997) 0.80
Characterization of an atypical lipoprotein-binding protein in human aortic media membranes by ligand blotting. Biochem J (1994) 0.80
T-cadherin activates Rac1 and Cdc42 and changes endothelial permeability. Biochemistry (Mosc) (2009) 0.80
Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension. J Hypertens Suppl (1991) 0.80
Rat aortic smooth muscle cells expressing charybdotoxin-sensitive potassium channels exhibit enhanced proliferative responses. Clin Exp Pharmacol Physiol (1994) 0.80
Beta-agonist-induced inhibitory-guanine-nucleotide-binding regulatory protein coupling to adenylate cyclase in mollusc Anodonta cygnea foot muscle sarcolemma. Eur J Biochem (1992) 0.80
Evidence for involvement of a GTP-binding protein in activation of Ca2+ influx by epidermal growth factor in A431 cells: effects of fluoride and bacterial toxins. Cell Signal (1993) 0.79
[Biochemical features of platelet alpha2-adrenergic receptors and their connection with an increase in concentration of intracellular Ca2+]. Biokhimiia (1989) 0.79
Vascular signal transduction and atherosclerosis. Ann N Y Acad Sci (1990) 0.79
Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells. Arterioscler Thromb (1992) 0.79
Urokinase induces ROS production in vascular smooth muscle cells. Bull Exp Biol Med (2006) 0.79
Regulation of Immunity via Multipotent Mesenchymal Stromal Cells. Acta Naturae (2012) 0.79
Activation energy of skeletal muscle sarcolemmal Na+,K+-adenosine triphosphatase. Biochim Biophys Acta (1974) 0.78
Calcium-dependent interaction of dansyl-calmodulin and phosphodiesterase: relationship to Ca2+ requirement for enzyme activation. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 0.78
[Adipose tissue stromal cells -- multipotent cells with therapeutic potential for stimulation of angiogenesis in tissue ischemia]. Kardiologiia (2006) 0.78
Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment. Br J Pharmacol (2001) 0.78
Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: individual, additive and synergistic effects. J Vasc Res (1995) 0.78
[T-cadherin suppresses the cell proliferation of mouse melanoma B16F10 and tumor angiogenesis in the model of the chorioallantoic membrane]. Ontogenez (2010) 0.78
Stimulation of non-selective cation channels providing Ca2+ influx into platelets by platelet-activating factor and other aggregation inducers. Eur J Biochem (1991) 0.78
Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins. Atherosclerosis (1992) 0.77
Epinephrine potentiates activation of human platelets by low density lipoproteins. Biochim Biophys Acta (1991) 0.77
Molecular modeling as a new approach to the development of urokinase inhibitors. Bull Exp Biol Med (2015) 0.77
Identification of 130 kDa cell surface LDL-binding protein from smooth muscle cells as a partially processed T-cadherin precursor. Biochim Biophys Acta (1999) 0.77
Monocyte integrin expression and monocyte-platelet complex formation in humans with coronary restenosis. Clin Exp Pharmacol Physiol (2001) 0.77
The regulatory effect of ATP and its non-hydrolyzed analogs on heart adenylate cyclase. Biochem Int (1983) 0.77
Interaction between kringle and growth-factor-like domains in the urokinase molecule: possible role in stimulation of chemotaxis. Biochemistry (Mosc) (2008) 0.77
[The role of desensitization of glucocorticoid receptors in the development of vascular resistance to endogenous vasoconstrictors in traumatic shock]. Vestn Ross Akad Med Nauk (2007) 0.77
Abnormal cellular calcium regulation in essential hypertension. J Cardiovasc Pharmacol (1986) 0.77
[Phorbol ester blocks the coupling of GTP-binding protein with receptor-controlled calcium channels]. Biokhimiia (1989) 0.77
Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. Thromb Res (1988) 0.77
[Effect of pH on Ca-binding properties of calmodulin and on its interaction with Ca-dependent phosphodiesterase of cyclic nucleotides]. Biokhimiia (1981) 0.77
Stimulation of high-affinity hormone-sensitive GTPase of human platelets by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphocholine (platelet activating factor). Biochem Biophys Res Commun (1985) 0.77
[Therapeutic Angiogenesis Using Growth Factors: Current State and Prospects for Development]. Kardiologiia (2015) 0.77
Alterations in beta-adrenoceptor density on T-lymphocytes upon activation with interleukin-2 and phytohaemagglutinin. Biomed Sci (1990) 0.77
Urokinase plasminogen activator system in humans with stable coronary artery disease. Clin Exp Pharmacol Physiol (1999) 0.77
Characteristics of smooth muscle cell lipoprotein binding proteins (p105/p130) as T-cadherin and regulation by positive and negative growth regulators. Biochem Biophys Res Commun (1998) 0.76
[Genetic factors of risk of ischemic heart disease development in patients with familial hypercholesterolemia]. Kardiologiia (2005) 0.76
Evidence for the receptor-operated calcium channels in human platelet plasma membrane. Thromb Res (1987) 0.76
Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): effects on intracellular calcium and platelet aggregation. Cardiovasc Drugs Ther (1995) 0.76
Calmodulin and troponin C as targets for drug action. Biomed Biochim Acta (1987) 0.76
Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil. FEBS Lett (1984) 0.76
Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. Int J Cardiol (1990) 0.76
Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967). Membr Cell Biol (2000) 0.76
Selective inactivation by endogenous protein kinase C of human platelet high-affinity GTPase coupled with PAF receptors. J Mol Cell Cardiol (1989) 0.76
[UROKINASE SYSTEM INVOLVES IN VASCULAR CELLS MIGRATION AND REGULATES THE GROWTH AND BRANCHING OF CAPILLARIES]. Tsitologiia (2015) 0.76
[Mechanism of stimulation of angiogenesis in ischemic myocardium with the help of adipose tissue stromal cells]. Kardiologiia (2010) 0.76
LDL- and agonist-induced Ca(2+)-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II. Thromb Res (1991) 0.76
Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta. Am J Cardiol (1988) 0.76
Comparison of binding of 3H-desmethoxyverapamil and 3H-mibefradil in vascular smooth muscle and heart membranes. Possible binding of mibefradil to a site distinct from the phenylalkylamine-binding site. Arzneimittelforschung (1996) 0.76
Platelet calcium-linked abnormalities in essential hypertension. Ann N Y Acad Sci (1986) 0.76
[Molecular mechanisms of gradient sensing in mesenchymal cells]. Ross Fiziol Zh Im I M Sechenova (2013) 0.75
[Hypoxia as the main activator of angiogenesis and fatty tissue growth]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
[Tasks of pharmacy workers of the Republic in fulfilling the socialist obligations of the 2d year of the 10th Five-Year Plan]. Farm Zh (1977) 0.75